Story Poster
Photo by Morgan Kates, TexAgs
Texas A&M Baseball

Texas A&M closer Nolan Hoffman a second-team All American

June 18, 2018
9,707

Texas A&M junior closer Nolan Hoffman, known for a distinctinve side-arm delivery and constant self-talk on the mound, has been named to the American Baseball Coaches Association/Rawlings All-America Second Team. Hoffman tied the program record with 14 saves, adding a 4-1 record and an impressive 1.15 ERA.

Hoffman, who transferred to A&M from Hutchinson Community College prior to the 2018 season, quickly endeared himself to the Aggie faithful. His unorthodox delivery and dominant pitching followed an entertaining pre-pitch routine.

Hoffman carried on a constant conversation with himself on the mound, but he has declined to disclose any details of his often demonstrative chatter. At one point in the season he told the media he doesn't say anything to himself, though it was unclear if that was a joke or if perhaps his words are for the hitter in the box.

Hoffman racked up 53 strikeouts in 55 innings of work this season, often putting in more time than a typical closer in his 33 appearances. He worked more than a full inning in 11 of his 14 saves, including a 3 inning save in a 3-1 win against Vanderbilt in the first round of the SEC Tournament in May.

A right-hander with a sinker that pushes into the 90s and a strong slider, Hoffman was drafted in the 5th round of the MLB draft by Seattle. Last week he signed a $300,000 contract with the Mariners.

Discussion from...

Texas A&M closer Nolan Hoffman a second-team All American

7,049 Views | 2 Replies | Last: 5 yr ago by Foxo
Chester
How long do you want to ignore this user?
What coach do you think made him into an All-American? This question is for the anti-Childress posters.
Foxo
How long do you want to ignore this user?
AG
Give it up. Many (most) Aggie fans just watch sports to call for the coach's head.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.